Increased ATF5 expression has been reported in aggressive chronic lymphocytic leukemia (57), follicular lymphoma (58), and childhood acute lymphoblastic leukemia (59), implying potential involvement of ATF5 in the tumorigenesis and progression of these hematopoietic malignancies. The gene discussed is ATF5; the disease is B-cell chronic lymphocytic leukemia.